BioSpace News Archive

Geistlich Pharma North America Inc. is pleased to announce that our Executive Chairman, Dr. Andreas Geistlich, has been awarded the prestigious American Association of Oral and Maxillofacial Surgeons Board of Trustees Special Citation Award for the company’s exceptional and longstanding contributions to the field of Oral and Maxillofacial Surgery.

GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, today announced interim findings of a multi-institutional study that demonstrates high local control for the treatment of recurrent brain metastases in patients, adding to the growing evidence of the efficacy and safety of its FDA-approved GammaTile® Therapy at the American Society for Radiation Oncology’s (ASTRO) 65th Annual Meeting.

Abivax SA (Euronext Paris:FR0012333284 - ABVX) (“Abivax” or the “Company”) today announced that three scientific abstracts on its lead drug candidate, obefazimod, will be presented during the United European Gastroenterology (UEG) Week meeting, October 14-17, 2023, in Copenhagen, Denmark.

Stryker announced that it will report financial results for third quarter of fiscal year 2023 on Thursday, November 2, 2023.

Cytokinetics, Incorporated, announced upcoming presentations at the 2023 Hypertrophic Cardiomyopathy Medical Society Scientific Sessions on October 6, 2023, and at the Heart Failure Society of America Annual Scientific Meeting, taking place from October 6-9, 2023, both taking place in Cleveland, OH.

Nucleix Announces Upcoming Presentation of Performance Data from Sightline Study of Lung EpiCheck ® at the American College of Chest Physicians (CHEST) 2023 Annual Meeting.

Amicus Therapeutics today announced that it has entered into a definitive agreement for a $430 million financing collaboration with funds managed by Blackstone Life Sciences and Blackstone Credit have agreed to provide Amicus with a $400 million senior secured term loan facilitating a refinancing of existing debt and a $30 million strategic investment in Amicus’s common stock.

Cutera, Inc. is pleased to announce the appointment of Brent Hauser as President, International, effective October 2, 2023.

Syros Pharmaceuticals today announced a strategic realignment to prioritize key development and pre-launch activities to advance tamibarotene for the frontline treatment of higher-risk myelodysplastic syndrome (HR-MDS) and acute myeloid leukemia (AML).

Coherus BioSciences, Inc. announced recognition and support for Rare Cancer Day to raise awareness for rare cancers such as nasopharyngeal carcinoma.